Huawei Releases Top 10 Construction Guidelines for Intelligent Computing Center Facilities

SHANGHAI, Sept. 20, 2024 /PRNewswire/ -- On September 19, 2024, Huawei Digital Power held the Data Center Facility Summit during HUAWEI CONNECT 2024 in Shanghai. More than 300 industry leaders and experts gathered to explore new trends and technologies of the data center industry for the intelligent computing era. By accelerating industry intelligence, they aim to build a thriving industry ecosystem and create a brilliant future of intelligent computing to power the digital era forward.

Steve Kim, President of Huawei Data Center Facility & Critical Power Business, shared valuable insights in the opening speech: The intelligent computing era is coming fast, posing higher requirements for data centers. Huawei leverages its highly reliable products, global ecosystem, and professional services to develop reliable, simple, green, and smart data center facility solutions.

According to Kim, Huawei Digital Power is eager to work with industry leaders and elites to redefine data center reliability with stricter safety and quality standards, promote healthy industry development, and embrace new opportunities of intelligent transformation to power the digital era forward.

During the summit, Bob He, President of Huawei Data Center Facility & Critical Power Product Line, delivered a keynote speech on "Embrace the Intelligent Computing Era, Power the Digital Era Forward."

Mr. He highlights that as data centers evolve from general-purpose to AI computing, they face challenges such as security, high power density, high energy consumption, and uncertainty. Huawei proposes "Reliable, Flexible, and Sustainable" and has released top 10 construction guidelines for intelligent computing center facilities to build reliable data center for intelligent computing, aiming to power the digital era forward.

1. Isolated energy storage: Deploying an energy storage system outdoors isolates it from IT services, maximizing data center safety. If deployed indoors, it must meet fire resistance, water fire extinguishing, and emergency ventilation requirements.
2. Distributed architecture: Deploy electromechanical equipment in a distributed mode to minimize fault domains. One power or cooling system can be deployed in a single container to prevent fault spreading and service impact.
3. Continuous cooling: Data centers should ensure continuous cooling for high-density equipment to prevent service interruptions during abnormalities.
4. High-reliable products: Product quality should be managed comprehensively throughout design, incoming materials, production, testing, networks, and processes, delivering high-quality products to ensure end-to-end safety.
5. Professional services: Professional and proactive services from deployment to maintenance eliminate risks and ensure that systems run reliably for a long term.
6. Smart management: AI technologies can prevent faults like power failure, fire, and overheating in data centers, making it essential for smart O&M.

7. Subsystem decoupling: To address uncertain requirements in the intelligent computing era, subsystem decoupling can be adopted to meet basic requirements for flexible evolution of data centers.
8. Flexible architecture: Standardization, modular design, and prefabricated modules enhance data center flexibility, enabling smooth expansion and quick delivery of intelligent computing centers.

9. High density and efficiency: High-density deployment and high-efficiency design save space and energy for electromechanical equipment in intelligent computing centers.
10. Air-liquid convergence: Air-liquid convergence and an adjustable air-liquid ratio can reduce the total demand for cooling capacity, simplify delivery, and improve the energy-saving performance of systems.

Huawei will cooperate with customers and partners to embrace new changes in intelligent computing and innovate continuously to develop reliable, flexible, and sustainable data center facility solutions. Huawei will accelerate digital and intelligent transformation to unleash infinite potential and power the digital era forward.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Huawei Releases Top 10 Construction Guidelines for Intelligent Computing Center Facilities

BARCELONA, Spain, Sept. 20, 2024 /PRNewswire/ -- The highly anticipated 2024 European Society for Medical Oncology (ESMO) Annual Congress has taken place from September 13 to 17 in Barcelona, Spain. As one of the most influential annual gatherings in oncology, this congress brings together leading cancer experts and researchers from around the globe, showcasing the latest advancements in the field and providing high-quality educational and networking opportunities for oncology professionals.

Biosyngen, an innovative biotechnology company specializing in immune cell therapies, has showcased its groundbreaking technology on gene-modified, functionally enhanced tumor-infiltrating lymphocytes (TILs) derived from liver cancer biopsy samples.

BioSyngen has secured ten clinical trial approvals in China and the U.S. for its innovative fourth-generation oncology therapies. Currently, our leading pipeline product, BRG01, is in the pivotal Phase II clinical trial stage for solid tumors. Additionally, the first patients have been enrolled in the Phase I trials for our other groundbreaking therapies, BST02 and BRL03, with completion of Phase I trials anticipated later this year.

Abstract Title

Pre-clinical Development of Genetically Modified Tumor-infiltrating Lymphocytes using Biopsy Samples from Liver Cancer Patients

Abstract No.

1034P

Tumor-infiltrating lymphocytes (TILs) are heterogeneous lymphocyte populations within the tumor microenvironment that contains T cells capable of recognizing tumor- or virus-associated antigens. In February of this year, the FDA approved the first TIL-based therapy used with IL-2 for advanced metastatic/recurrent melanoma. However, due to the variability in T cell infiltration between hot and cold tumors, differential abundance of antigen-specific T cells with robust immune response functionality, and the dependence of TIL anti-tumor efficacy on concomitant use of high-dose IL-2 combination therapy, the therapeutic applications of non-edited TILs are quite limited outside of melanoma.

To address these challenges, Biosyngen has developed a proprietary platform for expanding TILs from biopsy samples, achieving production of 10¹¹ cells within four weeks. Additionally, the company has established a stable gene modification platform that reprograms TIL metabolism, enhances TIL activity and sustained antitumor efficacy by expressing membrane anchor proteins. Anti-tumor efficacy has significantly enhanced (without IL-2 co-injection) and no obvious toxicity observed.

Biosyngen houses best-in-class proprietary TIL platform aiming to expand the clinical applications of TIL technology with following features:

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte (TIL) Technology Debuts on ESMO 2024 Annual Meeting

Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte (TIL) Technology Debuts on ESMO 2024 Annual Meeting